Showing results (41-50 of 80) with videos related to
Sort By:
Pageof 8
Japanese Journal of Cancer Research : Gann|June 25, 2002
MUM1/IRF4 expression is an unfavorable prognostic factor in B-cell chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)Masato Ito, Shinsuke Iida, Hiroshi Inagaki, et al.International Journal of Hematology|March 1, 2021
Early central nervous system relapse of monomorphic epitheliotropic intestinal T-cell lymphoma after cord blood transplantationYuma Nato, Kana Miyazaki, Hiroshi Imai, et al.Journal of Clinical and Experimental Hematopathology : JCEH|December 27, 2022
Combined use of pathological and genomic alteration analyses for the diagnosis of gray zone lymphomaKomei Nishimura, Kana Miyazaki, Kazutaka Suzuki, et al.International Journal of Hematology|January 31, 2007
Clinicopathologic significance of loss of CD19 expression in diffuse large B-cell lymphomaMiho Kimura, Motoko Yamaguchi, Shigeo Nakamura, et al.Cancer Science|February 26, 2008
Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemiaMotoko Yamaguchi, Ritsuro Suzuki, Yok-Lam Kwong, et al.Cancer Research|September 3, 2004
Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: comparison between CD5-positive and CD5-negative casesHiroyuki Tagawa, Shinobu Tsuzuki, Ritsuro Suzuki, et al.Leukemia|January 7, 2026
Advances in the treatment and prognosis of aggressive NK-cell leukemia: results from the ANKL22 studyAyumi Fujimoto, Takeshi Maeda, Noriko Doki, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 9, 2018
[Atypical hemolytic uremic syndrome with C3 p.I1157T missense mutation successfully treated with eculizumab]Motohiko Okano, Takeshi Matsumoto, Yoshiki Nakamori, et al.European Journal of Haematology|November 13, 2010
Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphomaHirokazu Nagai, Michinori Ogura, Shigeru Kusumoto, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2015
[Relapse in the nasal cavity of a patient with extranodal NK/T-cell lymphoma initially presenting as plantar subcutaneous tumor]Haruna Sakaguchi, Kana Miyazaki, Yasutaka Tono, et al.Pageof 8